Oclazid MR 30 mg (Tablet (Modified Release))

Title

• Oclazid MR 30 mg Tablet

Categories

• Medicine
• Diabetes Management

Description

• Reduces blood sugar levels
• Belongs to the sulphonylurea group of oral antidiabetic medicines
• Used for type 2 diabetes Mellitus in adults
• Dose range: 40 to 320 mg daily
• Can be taken before meal
• Recommended daily dose for modified release preparation: 120 mg
• Can be taken with or without food and non-alcoholic drinks
• May cause low blood sugar (hypoglycaemia)
• Can cause liver disorders, skin disorders, blood disorders, digestive disorders, and eye disorders as side effects
• Not recommended for use during pregnancy or breastfeeding
• Storage temperature below 30°C
• Molecular Formula: C15H21N3O3S

Dimensions

• Film-coated tablet: unspecified
• Modified release preparation: unspecified

Color options

• Unspecified

Usability features

• Encourages pancreas to release more insulin
• Improves body's ability to use insulin
• Regular monitoring of blood sugar levels and glycated haemoglobin necessary
• Ability to carry sugary candy for treating low blood sugar

Materials

• Active ingredient: Gliclazide

Technical specifications

• Stimulates the release of insulin from pancreatic β-cells
• Facilitates Ca⁺² transport across the β-cell membranes
• Decreases hepatic glucose output

Design elements

• Film-coated tablet: unspecified
• Modified release preparation: unspecified

Functions

• Low blood sugar reduction
• Blood sugar level maintenance in type 2 diabetes

Dosage instructions

• Initial dose: 40 to 80 mg daily
• Usual daily dose for modified release: 1 to 4 tablets (maximum 120 mg)
• Take 30 minutes before breakfast
• Do not chew or crush tablets
• Regular monitoring of blood and urine sugar levels required

Storage instructions

• Store below 30°C
• Do not use after expiry date
• Keep out of reach and sight of children
• Do not dispose of via wastewater or household waste

Interaction

• May interact with oral antidiabetic medicines, GLP-1 receptor agonists, insulin, antibiotics, medicines for high blood pressure or heart failure, medicines for fungal infections, medicines for ulcers, medicines for depression, painkillers, antirheumatics, and more
• May increase effects of medicines that reduce blood clotting
• Consult doctor before starting another medicinal product

Contraindications

• Allergic to Gliclazide or related medicines
• Insulin-dependent diabetes, ketone bodies, and sugar in urine
• Severe kidney or liver disease
• Taking medicines to treat fungal infections
• Breastfeeding

Side effects

• Low blood sugar (hypoglycaemia)
• Liver disorders
• Skin disorders
• Blood disorders
• Digestive disorders
• Eye disorders
• Possible severe hypersensitivity reactions

Pregnancy & lactation

• Not recommended for use during pregnancy
• Not recommended for use while breastfeeding

Precautions & warnings

• Observe treatment plan prescribed by doctor
• Regular monitoring of blood sugar levels and glycated haemoglobin necessary
• Increased risk of hypoglycaemia in the first few weeks of treatment
• Low blood sugar may occur due to various factors including malnutrition, diet changes, physical activity, alcohol consumption, and more
• Not recommended for use in children

Therapeutic Class

• Sulfonylureas

Chemical Structure

• Molecular Formula: C15H21N3O3S

Common Questions

• Dose tied to meals
• Instructions for missed dose
• Average duration of effect: 24 hours
• Not recommended for pregnant women
• Take as directed by doctor
• Monitor blood sugar levels regularly
• Carry sugary candy for treating hypoglycaemia

Related Brands

• Remicron MR 60 mg (Tablet (Modified Release)) - sun-pharmaceutical-bangladesh-ltd
• Remicron MR 30 mg (Tablet (Modified Release)) - sun-pharmaceutical-bangladesh-ltd
• Glucostat MR 60 mg (Tablet (Modified Release)) - biopharma-limited
• Uzide 80 mg (Tablet) - union-pharmaceuticals-ltd
• Gored MR 60 mg (Tablet (Modified Release)) - general-pharmaceuticals-ltd